Clinical trial of ambroxol (Mucosolvan) in Sjögren's syndrome.
Ichikawa Y, Tokunaga M, Shimizu H, +3 more·The Tokai journal of experimental and clinical medicine
A clinical trial is described in which twelve patients with Sjögren's Syndrome (SS) were given a dose of 135 mg ambroxol (Mucosolvan) daily for eight weeks. Nine of the patients completed the trial. Three patients dropped out because they developed side effects (generalized rashes in two patients and stomatitis in…